Ethic Inc. Biogen Inc. Transaction History

Ethic Inc.

$4.22 Billion
Q2 2024

A detailed history of Ethic Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Ethic Inc. holds 7,860 shares of BIIB stock, worth $1.37 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,860

Previous 7,169 9.64%

Holding current value

$1.37 Million

Previous $1.55 Million 17.93%

% of portfolio

0.04%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $131,649 - $163,573	691 Added 9.64%	7,860 $1.82 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $1.42 Million - $1.79 Million	-6,690 Reduced 48.27%	7,169 $1.55 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $1.4 Million - $1.69 Million	6,290 Added 83.1%	13,859 $3.59 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $437,955 - $494,303	1,729 Added 29.61%	7,569 $1.95 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $142,304 - $164,437	-517 Reduced 8.13%	5,840 $1.66 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $742,484 - $846,031	-2,894 Reduced 31.28%	6,357 $1.77 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $1.02 Million - $1.24 Million	4,048 Added 77.8%	9,251 $2.56 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $327,273 - $451,281	1,681 Added 47.73%	5,203 $1.39 Million
Q2 2022 Aug 10, 2022	BUY	$187.54 - $223.02 $192,228 - $228,595	1,025 Added 41.05%	3,522 $718,000
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $63,362 - $79,833	327 Added 15.07%	2,497 $526,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $173,761 - $223,309	-776 Reduced 26.34%	2,170 $521,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $211,393 - $275,680	747 Added 33.97%	2,946 $834,000
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $44,030 - $70,500	-170 Reduced 7.18%	2,199 $761,000
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $125,119 - $146,584	515 Added 27.78%	2,369 $663,000
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $202,474 - $304,774	857 Added 85.96%	1,854 $454,000
Q3 2020 Oct 27, 2020	SELL	$264.77 - $305.71 $199,107 - $229,893	-752 Reduced 43.0%	997 $283,000
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $28,711 - $38,023	-111 Reduced 5.97%	1,749 $468,000
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $43,553 - $55,248	162 Added 9.54%	1,860 $588,000
Q4 2019 May 22, 2020	BUY	$220.06 - $304.07 $38,070 - $52,604	173 Added 11.34%	1,698 $504,000
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $335,591 - $463,706	1,525 New	1,525 $453,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account